[Case report on therapy for HIT II from an assessor's point of view].
Haas
S
S
Institut für Experimentelle Onkologie und Therapieforschung der Technischen Universität München, Klinikum rechts der Isar, Germany.
D000925:Anticoagulants / Q000009:adverse effects*; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000628:therapy
D000925:Anticoagulants; D006493:Heparin